Sperm Selection by Microfluidic Separation Improves Embryo Quality (SPERM)
Sponsor: University of California, San Francisco
Listed as NCT03085433, this NA trial focuses on Embryo Quality and Fertility Disorders and remains completed. Sponsored by University of California, San Francisco, it has been updated 14 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Jan 2026 — Present [monthly]
Completed NA
-
Sep 2024 — Jan 2026 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2022 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2022 — Dec 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 9 earlier versions
-
Sep 2021 — Jan 2022 [monthly]
Recruiting NA
-
Mar 2021 — Sep 2021 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Active Not Recruiting NA
-
Jul 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting · Phase: PHASE3 → NA
-
Dec 2019 — Jul 2020 [monthly]
Recruiting PHASE3
-
Nov 2018 — Dec 2019 [monthly]
Recruiting PHASE3
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE3
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Apr 2017 — Nov 2017 [monthly]
Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .